Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
---|---|---|---|
USD 32.92 Billion | USD 75.11 Billion | 8.6% | 2024 |
The global diabetes care devices market size was worth around USD 32.92 Billion in 2024 and is predicted to grow to around USD 75.11 Billion by 2034 with a compound annual growth rate (CAGR) of roughly 8.6% between 2025 and 2034.
The report analyzes the global diabetes care devices market's drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the diabetes care devices industry.
Diabetes care equipment is utilized for monitoring glucose levels of diabetics. Furthermore, these instruments enable insulin delivery into body of patient. In addition to this, diabetes is a chronic condition in which pancreas fails to produce enough amount of insulin for regulating sugar in human system. For the record, diabetes was tenth biggest mortality cause in 2019 as it was responsible for nearly 2 million deaths. Such incidences have prompted demand for diabetes care devices across globe.
The increasing demand for diabetes devices is attributed to preventing longer hospital stays and higher mortality rates in diabetic patients. As these devices facilitate continuous monitoring and management of blood sugar levels, they empower patients to proactively address their condition, thereby potentially avoiding severe complications that could necessitate extended hospitalization. Moreover, by enabling timely adjustments to treatment regimens, these devices contribute to better disease management and outcomes, ultimately leading to improved quality of life for individuals with diabetes. As a result, the increasing use of diabetes devices highlights their vital importance in improving patient care and well-being.
The market is growing due to the increasing prevalence of diabetes resulting from aging, obesity, and unhealthy lifestyle choices. Obesity is a significant factor leading to diabetes. According to the National Center for Biotechnology Information (NCBI) in October 2023, if the current trends continue, by 2035, more than half of the world's population will be overweight or obese, and the majority of new diabetes cases will be type 2 diabetes, driven by shifts in obesity rates and dietary risks. Factors such as overweight and obesity are contributing to a rise in diabetes cases. Consequently, risk factors like smoking, being overweight or obese, and having high cholesterol levels are anticipated to elevate the prevalence of diabetes, thereby increasing the demand for diabetes devices.
Rise in cases of diabetics owing to inactive lifestyle along with swift industrialization will steer diabetes care devices market size. Furthermore, use of advanced blood glucose monitoring tools along with minimally invasive insulin delivery equipment for detecting diabetes has resulted in humungous demand for diabetes care devices in healthcare sector. Moreover, obesity issues and prominent surge in number of diabetes patients will fuel expansion of diabetes care devices market.
Furthermore, diabetes is assessed to be related to nearly 11.2% of global deaths across globe in coming years. Rising awareness pertaining to treatment of diabetes and supportive national health plans are set to expedite expansion of diabetes care devices industry. Moreover, diabetes is occurring at higher frequency in youth owing to irregular working hours and food habits. These, in turn, have created massive need of diabetes care devices in healthcare sector, thereby driving market progress.
The global diabetes care devices market is segmented based on Glucose Monitoring Device, Insulin Delivery Device, and region.
Based on Glucose Monitoring Device, the global diabetes care devices market is divided into Blood Glucose Meters, Blood Glucose Test Strips, Lancing Devices, Continuous Glucose Monitoring Devices, HbA1c Testing Kits, And Others.
On the basis of Insulin Delivery Device, the global diabetes care devices market is bifurcated into Insulin Pumps, Insulin Syringes, And Insulin Pens.
Report Attributes | Report Details |
---|---|
Report Name | Diabetes Care Devices Market |
Market Size in 2024 | USD 32.92 Billion |
Market Forecast in 2034 | USD 75.11 Billion |
Growth Rate | CAGR of 8.6% |
Number of Pages | 150 |
Key Companies Covered | Terumo Corporation, Acon Laboratories Inc., Abbott Laboratories, Dexcom Inc., Novo Nordisk A/S, Johnson & Johnson, Bayer AG, Merck & Co. Inc., The Ypsomed Group, Roche Diagnostics Ltd., Becton, Dickinson and Company, Medtronic plc, ARKRAY Inc., Sanofi S.A.,, and others. |
Segments Covered | By Glucose Monitoring Device, By Insulin Delivery Device, and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, The Middle East and Africa (MEA) |
Base Year | 2024 |
Historical Year | 2020 to 2023 |
Forecast Year | 2025 - 2034 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
North American Diabetes Care Devices Market To Record Astounding Growth By 2034
Growth of diabetes care devices market in North America over forecasting timeline is subject to rise in number of diabetics in North America. For the record, recently there are over 30 million diabetics in North America and the number is projected to surge to about 34 million in 2026. Furthermore, supportive reimbursement guidelines along with strong presence of healthcare infrastructure in countries such as the U.S. and Canada will proliferate regional market surge.
The report provides a company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments of the market, including acquisitions & mergers, new product launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the diabetes care devices market on a global and regional basis.
The global diabetes care devices market is dominated by players like:
By Glucose Monitoring Device
By Insulin Delivery Device
By Region
FrequentlyAsked Questions
Leading players in the global diabetes care devices market include Terumo Corporation, Acon Laboratories Inc., Abbott Laboratories, Dexcom Inc., Novo Nordisk A/S, Johnson & Johnson, Bayer AG, Merck & Co. Inc., The Ypsomed Group, Roche Diagnostics Ltd., Becton, Dickinson and Company, Medtronic plc, ARKRAY Inc., Sanofi S.A.,, among others.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed